Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7837195 in Moderate to Severe Active Ulcerative Colitis (China) – Phase IIb
CTR20254876Phase 2Active
- Sponsor
- Genentech
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RO7837195 in autoimmune colitis, sponsored by Genentech. Started Apr 2026; status: active.
02
Drugs
RO7837195
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20254876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254876.